跳转至内容
Merck
CN
  • Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration.

Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2020-01-29)
Min Joung Lee, Yunseon Jang, Jeongsu Han, Soo J Kim, Xianshu Ju, Yu Lim Lee, Jianchen Cui, Jiebo Zhu, Min Jeong Ryu, Song-Yi Choi, Woosuk Chung, Chaejeong Heo, Hyon-Seung Yi, Hyun Jin Kim, Yang H Huh, Sookja K Chung, Minho Shong, Gi-Ryang Kweon, Jun Young Heo
摘要

Cerebral endothelial cells (ECs) require junctional proteins to maintain blood-brain barrier (BBB) integrity, restricting toxic substances and controlling peripheral immune cells with a higher concentration of mitochondria than ECs of peripheral capillaries. The mechanism underlying BBB disruption by defective mitochondrial oxidative phosphorylation (OxPhos) is unclear in a mitochondria-related gene-targeted animal model. To assess the role of EC mitochondrial OxPhos function in the maintenance of the BBB, we developed an EC-specific CR6-interactin factor1 (Crif1) deletion mouse. We clearly observed defects in motor behavior, uncompacted myelin and leukocyte infiltration caused by BBB maturation and disruption in this mice. Furthermore, we investigated the alteration in the actin cytoskeleton, which interacts with junctional proteins to support BBB integrity. Loss of Crif1 led to reorganization of the actin cytoskeleton and a decrease in tight junction-associated protein expression through an ATP production defect in vitro and in vivo. Based on these results, we suggest that mitochondrial OxPhos is important for the maturation and maintenance of BBB integrity by supplying ATP to cerebral ECs.

材料
货号
品牌
产品描述

Sigma-Aldrich
葡聚糖 来源于明串珠菌 属, Mr ~70,000
Sigma-Aldrich
(E/Z)-盐酸内多昔芬水合物, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human GADD45GIP1